Decreased COVID Antibody Response in MS Patients Taking Ocrelizumab ...Middle East

Antibody, but not T-cell, response appears to be attenuated in patients with MS who take the disease-modifying therapy ocrelizumab during COVID-19 infection, new research shows. Medscape Medical News

Hence then, the article about decreased covid antibody response in ms patients taking ocrelizumab was published today ( Thursday 13/05/2021 - 07:02 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Decreased COVID Antibody Response in MS Patients Taking Ocrelizumab )

Also on site :

• A decade after the ‘Godfather of AI’ said radiologists were obsolete, their salaries are up to $571K and demand is growing fast
• Quote of the Day: Organizational Psychologist Adam Grant on Rethinking Self-Doubt and Building Confidence
• Enbridge aims to help North America win from the AI boom and the Iran war as the FedEx of energy delivery